LMRI
Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ: LMRI · HEALTHCARE · MEDICAL DEVICES
$9.57
+2.13% today
Updated 2026-04-30
Market cap
$933.23M
P/E ratio
—
P/S ratio
0.91x
EPS (TTM)
$-0.66
Dividend yield
—
52W range
$7 – $19
Volume
0.9M
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $935.92M | $948.87M | $1.02B |
| Revenue growth (YoY) | — | +1.4% | +7.8% |
| Cost of revenue | $836.96M | $852.61M | $905.89M |
| Gross profit | $98.97M | $96.26M | $117.19M |
| Gross margin | 10.6% | 10.1% | 11.5% |
| R&D | — | — | — |
| SG&A | $55.16M | $70.36M | $90.45M |
| Operating income | $22.45M | $55.24M | $26.73M |
| Operating margin | 2.4% | 5.8% | 2.6% |
| EBITDA | $94.58M | $114.00M | $82.12M |
| EBITDA margin | 10.1% | 12.0% | 8.0% |
| EBIT | $22.45M | $56.83M | $26.73M |
| Interest expense | $141.69M | $136.03M | $118.54M |
| Income tax | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% |
| Net income | $-122.23M | $-94.10M | $-47.10M |
| Net income growth (YoY) | — | +23.0% | +49.9% |
| Profit margin | -13.1% | -9.9% | -4.6% |